Effects on infarct size of reperfusion and pretreatment with beta-blockade and calcium antagonists
- PMID: 2575896
- DOI: 10.1007/BF01906942
Effects on infarct size of reperfusion and pretreatment with beta-blockade and calcium antagonists
Abstract
The "mass of tissue at risk" and the myocardial infarct developed was studied in dogs subjected to either 24-h occlusion of the left anterior descending coronary artery or 2-h occlusion followed by 22-h reperfusion. The "mass of tissue at risk" was defined under anaesthesia at the time of occlusion using the microsphere technique. Twenty-four hours later the hearts were removed, sliced transversely and stained with 2,3,5-triphenyltetrazolium chloride to define the infarcted tissue. All myocardial tissue was mapped and cut into small pieces for weighing and radioactive counting. Radioactivity was present in all tissue, including the infarct. In the centre of the infarct, counts remained low and then increased very rapidly with distance just beyond the edge. Tissue at risk from infarction was taken as that with less than 15% of the peak left ventricular (non-ischaemic) counts. A linear relationship was found between the mass of the left ventricular infarct and the left ventricular "mass of tissue at risk". The effect of 22 hours reperfusion was examined by this method and expressed by a regression equation. There was a significant decrease in slope for the regression line of the reperfusion data, (p less than 0.05, analysis of covariance), indicating less infarcted tissue for each gram of underperfused tissue. None of the drug pretreatments explored had any effect on infarct size in the 24-h occlusion model. With reperfusion, propranolol and flunarizine diminished infarct size compared with reperfusion only (p less than 0.05 for reduced slope, the new slope being not significantly different from zero). The effect of diltiazem was not so marked. Thus infarct size can be reduced with pretreatment, as long as the myocardium is reperfused.
Similar articles
-
Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.Cardiovasc Res. 1992 May;26(5):518-25. doi: 10.1093/cvr/26.5.518. Cardiovasc Res. 1992. PMID: 1359930
-
Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).J Pharmacol Exp Ther. 1976 Nov;199(2):310-28. J Pharmacol Exp Ther. 1976. PMID: 978488
-
Reduction of myocardial ischemia-reperfusion injury by KT-362, a new intracellular calcium antagonist in anesthetized dogs.J Cardiovasc Pharmacol. 1989 Apr;13(4):586-93. J Cardiovasc Pharmacol. 1989. PMID: 2470996
-
Effects of calcium antagonists on infarcting myocardium.Am J Cardiol. 1987 Jan 30;59(3):84B-94B. doi: 10.1016/0002-9149(87)90087-7. Am J Cardiol. 1987. PMID: 3544791 Review.
-
Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?Cardiology. 1997;88 Suppl 1:3-14; discussion 15-6. doi: 10.1159/000177451. Cardiology. 1997. PMID: 9118166 Review.
Cited by
-
Effect of the ultrashort-acting beta-blocker Brevibloc on free-radical-mediated injuries during the early reperfusion state.Basic Res Cardiol. 1991 Sep-Oct;86(5):422-33. doi: 10.1007/BF02190710. Basic Res Cardiol. 1991. PMID: 1685083
-
Infarct size in rabbits: a modified method illustrated by the effects of propranolol and trimetazidine.Basic Res Cardiol. 1993 May-Jun;88(3):250-8. doi: 10.1007/BF00794997. Basic Res Cardiol. 1993. PMID: 8216176
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical